A pharma partners contract worth $667 million was jointly awarded by South Africa to three big names in the pharma world, Aspen Pharmacare, Abbott Laboratories and Adcock Ingram, to supply life-prolonging HIV medicine to 12 international and domestic firms, to deal with its biggest health problem.
The 5.9 billion rand ($667 million) pharma partners contract, effective from April next year, aims to increase the number of people on treatment by nearly 50 percent, to 2.5 million next year.
For further deal information visit Current Agreements (subscription required)
Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary
Report: Practical Guide to Finding Partners
Report: Partnering Deals and Alliances with Abbott Laboratories
Report: Partnering Deals and Alliances with Aspen Pharmacare
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity